Tuesday, April 16, 2019 11:36:58 AM
NO REVERSE SPLIT CONFIRMED PER CEO: PHONE# 520 288 1908
Authorized Shares 4,000,000,000 04/15/2019
Outstanding Shares 2,903,241,652 04/15/2019
Float: 672,168,892 10/31/2018
Tautachrome is an Internet and blockchain technology development company with revolutionary patents granted, pending and licensed, including Talk-to-the-Picture social networking, trustable imagery creation, and via an augmented reality based "ArKnet system" providing virtual interfacing between providers of household products & services, and the consumers of these goods & services. The Company is establishing a cryptotoken-based ecosystem to monetize this body of technology. The Company's top priority is developing its branded KlickZie platform which will turn smartphones into trustable imagers meaning they are capable of capturing pictures and videos that can be verified as original, untampered and un-photoshopped. Furthermore the KlickZie platform will serve as the world's first imagery-based social portal network. By clicking or touching a in the world who may be viewing the imagery. And finally, the Company's ArKnet system will provide virtual interfacing between consumers and providers in the global household goods and services marketplace.
https://www.otcmarkets.com/filing/html?id=13361222&guid=1yb3Uqzr1cCVxth
UPDATED: $TTCM INSIDERS OWN OVER 829MIILL SHARES LOOK NOW
PAGE 43
https://www.tautachrome.com/Tautachrome_Management.cfm
******$TTCM is also a SEC FILFER
https://www.sec.gov/Archives/edgar/data/1389067/000147793218003700/0001477932-18-003700-index.htm
https://myarknet.io/
******** WHITE PAPERS ******
https://img1.wsimg.com/blobby/go/b65cd93d-d85a-41a5-8808-103e8ef4565a/downloads/1cu0kb1cs_762585.pdf?ver=1554822444593
https://img1.wsimg.com/blobby/go/b65cd93d-d85a-41a5-8808-103e8ef4565a/downloads/1d2nolnmb_185715.pdf?ver=1554822444594
Due Dilligence is Vital. Give me a Member Mark if you want to consistently track winners with strong due dilligence behind it
Recent TTCM News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 07:30:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM